BIO-Europe® 2015: Interview with Sean Marett, BioNTech

November 19, 2015
BioNTech chief operating officer, Sean Marett, discusses his company's recent Sanofi immunotherapy deal with Mike Ward, global director of content for Informa Pharma Insights, at BIO-Europe in Munich, Germany. They chat about BioNTech's messenger RNA technology, co-development plans with Sanofi and the potential for immunotherapy combination studies. Find more videos and articles at http://www.partnering360.com/insight For more information on BIO-Europe, visit our webpage: http://www.ebdgroup.com/beu/index.php
Previous Video
Biotech Showcase™ 2016: Interview: Rigontec details immuno-oncology strategy
Biotech Showcase™ 2016: Interview: Rigontec details immuno-oncology strategy

Rigontec GmbH CEO Dr. Christian Schetter explains to Mike Ward, Informa Pharma Insights global director of ...

Next Video
BIO-Europe® 2015: Interview with Sander Slootweg, Forbion Capital Partners
BIO-Europe® 2015: Interview with Sander Slootweg, Forbion Capital Partners

Sander Slootweg, managing partner at Forbion Captial Partners, speaks to Mike Ward, global director of cont...